Literature DB >> 27092675

[Early detection of lung cancer using computed tomography among patients with chronic obstructive pulmonary disease].

Fernando Saldías P, Juan Carlos Díaz P, Carmen Rain M, Pamela Illanes C, Rodrigo Díaz T, Orlando Díaz P.   

Abstract

BACKGROUND: Chest computed tomography (CT) scan may improve lung cancer detection at early stages in high risk populations. AIM: To assess the diagnostic performance of chest CT in early lung cancer detection in patients with chronic obstructive pulmonary disease (COPD). PATIENTS AND METHODS: One hundred sixty one patients aged 50 to 80 years, active or former smokers of 15 or more pack-years and with COPD were enrolled. They underwent annual respiratory functional assessment and chest computed tomography for three years and were followed for five years.
RESULTS: Chest CT allowed the detection of lung cancer in nine patients (diagnostic yield: 5.6%). Three cases were detected in the initial CT and six cases in follow-up scans. Most patients were in early stages of the disease (6 stage Ia and 1 stage Ib). Two patients were diagnosed at advanced stages of the disease and died due to complications of cancer. Two thirds of patients had nonspecific pulmonary nodules on the initial chest CT scan (100 patients, 62%). Seventy four percent had less than three nodules and were of less than 5 mm of diameter in 57%. In 92% of cases, these were false positive findings. In the follow-up chest CT, lung nodules were detected in two thirds of patients and 94% of cases corresponded to false positive findings.
CONCLUSIONS: Chest CT scans may detect lung cancer at earlier stages in COPD patients.

Entities:  

Mesh:

Year:  2016        PMID: 27092675     DOI: 10.4067/S0034-98872016000200009

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  1 in total

1.  Contrast-enhanced computerized tomography combined with a targeted nanoparticle contrast agent for screening for early-phase non-small cell lung cancer.

Authors:  Ninglu Yuan; Xiaohe Zhang; Yonghui Cao; Xiaojie Jiang; Si Zhao; Yingying Feng; Yimeng Fan; Zhitao Lu; Hongmei Gao
Journal:  Exp Ther Med       Date:  2017-09-19       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.